PUBLISHER: Persistence Market Research | PRODUCT CODE: 1708022
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1708022
Dengue Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research has recently released a comprehensive report on the global Dengue Testing Market, offering an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
- Dengue Testing Market Size (2025E): US$ 583.5 Mn
- Projected Market Value (2032F): US$ 865.8 Mn
- Global Market Growth Rate (CAGR 2025 to 2032): 5.8%
Dengue Testing Market - Report Scope:
The Dengue Testing Market includes diagnostic tests used to detect the presence of the dengue virus in individuals suspected of being infected. These tests help determine whether a patient has dengue fever, which is caused by the dengue virus transmitted through mosquito bites. With increasing incidences of dengue in tropical and subtropical regions, along with rising healthcare awareness and advancements in diagnostic technology, the market is experiencing steady growth. The market includes a variety of testing methods such as ELISA-based tests, RT-PCR tests, and dengue rapid tests, which are primarily used in hospitals, diagnostic centers, and public health laboratories.
Market Growth Drivers:
The growth of the Dengue Testing Market is primarily driven by the increasing prevalence of dengue fever in tropical and subtropical regions, where the Aedes mosquitoes that transmit the virus are common. Global climate change, urbanization, and population mobility contribute to the rising number of dengue cases, making rapid and accurate diagnostics crucial. The growing demand for early detection and management of dengue fever is prompting healthcare facilities to adopt advanced diagnostic technologies. Furthermore, government initiatives to control dengue outbreaks and improve healthcare infrastructure, coupled with the rising adoption of point-of-care (POC) diagnostic tools, are key factors driving the market.
Market Restraints:
Despite the growing demand for dengue testing, several factors are restraining market growth. The high cost of diagnostic tests, particularly in low-income countries, limits the widespread adoption of advanced testing technologies. Additionally, the lack of infrastructure and trained personnel in remote and rural areas hampers the effective implementation of testing strategies. The variability in diagnostic accuracy between different testing methods, as well as challenges related to test availability and quality control, also poses challenges for the market. Moreover, limited awareness about the importance of early diagnosis in certain regions contributes to delayed testing, thereby impacting overall market growth.
Market Opportunities:
The Dengue Testing Market presents significant growth opportunities, particularly with advancements in molecular diagnostic techniques like RT-PCR, which offer higher sensitivity and specificity. The growing trend towards automation in laboratories and diagnostic centers presents an opportunity for the development of more efficient and faster testing solutions. Additionally, there is a growing focus on the development of multiplex diagnostic kits capable of detecting multiple infectious diseases, including dengue, which could drive market expansion. Emerging markets in regions like South Asia, Latin America, and Africa, where dengue outbreaks are frequent, provide a lucrative opportunity for market players. Increased investment in public health initiatives and the development of cost-effective testing options will further open up opportunities for market growth.
Key Questions Answered in the Report:
- What are the primary factors driving the global dengue testing market's growth?
- Which regions and market segments are experiencing the highest demand for dengue testing?
- How are innovations in diagnostic technologies influencing market dynamics?
- Who are the key players in the dengue testing market, and what strategies are they adopting to stay competitive?
- What are the emerging trends and future projections for the global dengue testing market?
Competitive Intelligence and Business Strategy:
Leading companies in the global dengue testing market, such as Abnova Corporation, Roche Molecular Systems Inc., Abbott Laboratories, InBios International, Inc., and others, are focusing on product innovation, strategic partnerships, and expanding their global presence. These companies are investing in research and development to improve the sensitivity and specificity of dengue tests. They are also exploring opportunities to expand their market reach through partnerships with public health organizations and diagnostic centers. Collaborating with governmental health agencies to provide affordable diagnostic solutions in endemic regions is becoming a key strategic focus to enhance market penetration.
Companies Covered in This Report:
- Abnova Corporation
- Roche Molecular Systems Inc.
- Abbott Laboratories
- InBios International, Inc.
- NovaTec Immundiagnostica GmbH
- Euroimmun AG (Sub. PerkinElmer)
- Quest Diagnostics
- Certest Biotec S.L.
- OriGene Technologies
Dengue Testing Market Segmentation:
By Product Type:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
By End-User:
- Hospitals
- Public Health Laboratories
- Diagnostic Centers
- Others
By Region:
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Dengue Testing Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. COVID-19 Impact Analysis
- 2.4. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Value Chain Analysis
- 3.2. Technology Adoption / Usage Analysis
- 3.3. Diseases Epidemiology
- 3.4. Key Market Players
- 3.5. Regulatory Landscape
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Forces Analysis
- 3.8. Consumer Behavior Analysis
4. Global Dengue Testing Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 4.3. Global Dengue Testing Market Outlook: Product Type
- 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
- 4.3.2. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
- 4.3.2.1. ELISA-based Tests
- 4.3.2.2. RT-PCR based Tests
- 4.3.2.3. Dengue IgG/IgM Rapid Test
- 4.3.2.4. Others
- 4.3.3. Market Attractiveness Analysis: Technology
- 4.4. Global Dengue Testing Market Outlook: End-User
- 4.4.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
- 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
- 4.4.2.1. Hospitals
- 4.4.2.2. Public Health Laboratory
- 4.4.2.3. Diagnostic Centers
- 4.4.2.4. Others
- 4.4.3. Market Attractiveness Analysis: End-User
5. Global Dengue Testing Market Outlook Region
- 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
- 5.2. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
- 5.2.1. North America
- 5.2.2. Latin America
- 5.2.3. Europe
- 5.2.4. East Asia
- 5.2.5. South Asia and Oceania
- 5.2.6. Middle East & Africa
- 5.3. Market Attractiveness Analysis: Region
6. North America Dengue Testing Market Outlook
- 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.1.1. By Country
- 6.1.2. By Product Type
- 6.1.3. By End-User
- 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 6.2.1. U.S.
- 6.2.2. Canada
- 6.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 6.3.1. ELISA-based Tests
- 6.3.2. RT-PCR based Tests
- 6.3.3. Dengue IgG/IgM Rapid Test
- 6.3.4. Others
- 6.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 6.4.1. Hospitals
- 6.4.2. Public Health Laboratory
- 6.4.3. Diagnostic Centers
- 6.4.4. Others
- 6.5. Market Attractiveness Analysis
7. Europe Dengue Testing Market Outlook
- 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.1.1. By Country
- 7.1.2. By Product Type
- 7.1.3. By End-User
- 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 7.2.1. Germany
- 7.2.2. France
- 7.2.3. U.K.
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Russia
- 7.2.7. Rest of Europe
- 7.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 7.3.1. ELISA-based Tests
- 7.3.2. RT-PCR based Tests
- 7.3.3. Dengue IgG/IgM Rapid Test
- 7.3.4. Others
- 7.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 7.4.1. Hospitals
- 7.4.2. Public Health Laboratory
- 7.4.3. Diagnostic Centers
- 7.4.4. Others
- 7.5. Market Attractiveness Analysis
8. East Asia Dengue Testing Market Outlook
- 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.1.1. By Country
- 8.1.2. By Product Type
- 8.1.3. By End-User
- 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 8.2.1. China
- 8.2.2. Japan
- 8.2.3. South Korea
- 8.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 8.3.1. ELISA-based Tests
- 8.3.2. RT-PCR based Tests
- 8.3.3. Dengue IgG/IgM Rapid Test
- 8.3.4. Others
- 8.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 8.4.1. Hospitals
- 8.4.2. Public Health Laboratory
- 8.4.3. Diagnostic Centers
- 8.4.4. Others
- 8.5. Market Attractiveness Analysis
9. South Asia & Oceania Dengue Testing Market Outlook
- 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.1.1. By Country
- 9.1.2. By Product Type
- 9.1.3. By End-User
- 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 9.2.1. India
- 9.2.2. Indonesia
- 9.2.3. Thailand
- 9.2.4. Singapore
- 9.2.5. ANZ
- 9.2.6. Rest of South Asia & Oceania
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 9.3.1. ELISA-based Tests
- 9.3.2. RT-PCR based Tests
- 9.3.3. Dengue IgG/IgM Rapid Test
- 9.3.4. Others
- 9.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 9.4.1. Hospitals
- 9.4.2. Public Health Laboratory
- 9.4.3. Diagnostic Centers
- 9.4.4. Others
- 9.5. Market Attractiveness Analysis
10. Latin America Dengue Testing Market Outlook
- 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.1.1. By Country
- 10.1.2. By Product Type
- 10.1.3. By End-User
- 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 10.2.1. Brazil
- 10.2.2. Mexico
- 10.2.3. Rest of Latin America
- 10.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 10.3.1. ELISA-based Tests
- 10.3.2. RT-PCR based Tests
- 10.3.3. Dengue IgG/IgM Rapid Test
- 10.3.4. Others
- 10.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 10.4.1. Hospitals
- 10.4.2. Public Health Laboratory
- 10.4.3. Diagnostic Centers
- 10.4.4. Others
- 10.5. Market Attractiveness Analysis
11. Middle East & Africa Dengue Testing Market Outlook
- 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.1.1. By Country
- 11.1.2. By Product Type
- 11.1.3. By End-User
- 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
- 11.2.1. GCC Countries
- 11.2.2. Egypt
- 11.2.3. South Africa
- 11.2.4. Northern Africa
- 11.2.5. Rest of Middle East & Africa
- 11.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
- 11.3.1. ELISA-based Tests
- 11.3.2. RT-PCR based Tests
- 11.3.3. Dengue IgG/IgM Rapid Test
- 11.3.4. Others
- 11.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
- 11.4.1. Hospitals
- 11.4.2. Public Health Laboratory
- 11.4.3. Diagnostic Centers
- 11.4.4. Others
- 11.5. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping by Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Thermo Fisher Scientific Inc.
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Sources
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Abnova Corporation
- 12.3.3. Roche Molecular Systems Inc.
- 12.3.4. Abbott Laboratories
- 12.3.5. InBios International, Inc.
- 12.3.6. NovaTec Immundiagnostica GmbH
- 12.3.7. Euroimmun AG (Sub. PerkinElmer)
- 12.3.8. Quest Diagnostics
- 12.3.9. Certest Biotec S.L.
- 12.3.10. OriGene Technologies
- 12.3.11. Jiangsu BioPerfectus Technologies Co., Ltd
- 12.3.12. Vitrosens Biyoteknoloji A.
- 12.3.13. ACON Biotech (Hangzhou) Co., Ltd.
- 12.3.14. Biozek
- 12.3.15. Mankind Pharma Pvt Ltd
- 12.3.16. Sun Pharmaceutical Industries Ltd
- 12.3.17. Others
- 12.3.1. Thermo Fisher Scientific Inc.
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
